Currency In USD
| Previous Close | 56.23 |
| Open | 56.19 |
| Day High | 57.15 |
| Day Low | 55.65 |
| 52-Week High | 57.17 |
| 52-Week Low | 34.08 |
| Volume | 2.46M |
| Average Volume | 3.74M |
| Market Cap | 24.56B |
| PE | 11.26 |
| EPS | 5.07 |
| Moving Average 50 Days | 52.65 |
| Moving Average 200 Days | 43.81 |
| Change | 0.86 |
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
GlobeNewswire Inc.
Mar 02, 2026 12:00 PM GMT
NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company’s royal
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
GlobeNewswire Inc.
Mar 02, 2026 11:10 AM GMT
Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaidZymeworks to retain 70% of royalties on Ziihera sales per the agreemen
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
GlobeNewswire Inc.
Feb 26, 2026 9:15 PM GMT
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 46th Annual Health Care Conference on March 3, 2026 at 1:10 p.m. ET. The webcast will be accessi